EDU 01 - Emerging Indications for Radiation in Poly-Metastatic Cancers
MODERATOR(S)
David Palma, MD, PhD - London Health Sciences Centre
session DESCRIPTION
This session is focused on new and emerging indications for radiation in patients with metastatic cancers. The speakers will discuss the use of radiation to achieve patient-centered goals, including extending survival, preventing complications (such as fractures from bony metastases, or morbidity from progression of primary tumors), and preserving quality of life. Each lecture will include a brief review of recent evidence, followed by practical advice for physicians who may wish to either 1) implement radiation for a new indication in their clinical practice, or 2) design or implement clinical trials at their center for that indication.
learning objectives
- Implement treatment for the new indications for radiation that are already established, as discussed by the speakers.
- Identify promising areas and potential future indications for radiation, and to begin processes to implement these in the future if desired (e.g., begin to build necessary multidisciplinary collaborations at their center).
- To better implement, analyze and discuss future trials of new technologies in radiation oncology, in light of the challenges in conducting radiation-related randomized trials.
Credits
AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
02:30pm - 04:00pm PT
Emerging Indications for Radiation in Poly-Metastatic Cancers
Speaker: David Palma, MD, PhD - London Health Sciences Centre, London -
02:30pm - 02:32pm PT
Introductions
Speaker: David Palma, MD, PhD - London Health Sciences Centre, London -
02:32pm - 02:47pm PT
ARRESTing More Than 10 Lesions with SABR: Insights from the ARREST and ARREST 2 Trials
Speaker: Tim Nguyen, MD - London Hospitals Science Centre, London -
02:47pm - 03:02pm PT
HALTing Oligoprogressive Cancers
Speaker: Fiona McDonald, MBBS, MA MRCP FRCR MD(Res) - The Royal Marsden, London -
03:02pm - 03:17pm PT
Integrating SABR with Immunotherapy and Other New Agents
Speaker: Jonathan Schoenfeld, MD - Brigham and Womens/Dana Farber Cancer Institute, Boston -
03:17pm - 03:32pm PT
Radiating High-Risk Primary Tumors in the Metastatic Setting: Different Strokes for Different Folks
Speaker: Melvin Lee Kiang Chua, MD, PhD - National Cancer Centre Singapore, Singapore -
03:32pm - 03:47pm PT
Looking Ahead: How Do We Generate Evidence to Support New Indications
Speaker: David Palma, MD, PhD - London Health Sciences Centre, London -
03:47pm - 04:00pm PT
Panel Discussion
Speaker: David Palma, MD, PhD - London Health Sciences Centre, London